[1]
“Pharmacoeconomic Assessment of the Application of Dornase Alfa in the Treatment of Lung Generation in Patients with Cystic Fibrosis”, AJP, vol. 12, no. 01, Jun. 2018, doi: 10.22377/ajp.v12i01.2216.